Your browser doesn't support javascript.
loading
Corrigendum to "The global threat of antimicrobial resistance: science for intervention" [New Microbes New Infect 6 (2015): 22-29].
Roca, I; Akova, M; Baquero, F; Carlet, J; Cavaleri, M; Coenen, S; Cohen, J; Findlay, D; Gyssens, I; Heuer, O E; Kahlmeter, G; Kruse, H; Laxminarayan, R; Liébana, E; López-Cerero, L; MacGowan, A; Martins, M; Rodríguez-Baño, J; Rolain, J-M; Segovia, C; Sigauque, B; Tacconelli, E; Wellington, E; Vila, J.
Affiliation
  • Roca I; ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
  • Akova M; Department of Medicine, Section of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey; ESCMID Executive Committee, Basel, Switzerland.
  • Baquero F; Department of Microbiology at the Ramón y Cajal University Hospital, Ramón y Cajal Institute for Health Research (IRYCIS), Division for Research in Microbial Biology and Evolution, CIBERESP, Madrid, Spain.
  • Carlet J; Fondation Hôpital St, Joseph, Paris, France and World Alliance Against Antibiotic Resistance (WAAAR), Creteil, France.
  • Cavaleri M; European Medicines Agency (EMA), London, UK.
  • Coenen S; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Cohen J; Brighton and Sussex Medical School, Brighton, UK.
  • Findlay D; Global Commercial Lead, GlaxoSmithKline (GSK), London, UK.
  • Gyssens I; Department of Medicine, Radboud University Medical Center and Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
  • Heuer OE; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Kahlmeter G; Clinical Microbiology, Central Hospital, Växjö, Sweden; ESCMID Executive Committee, Basel, Switzerland; EUCAST Steering Committee, Växjö, Sweden.
  • Kruse H; WHO Regional Office for Europe, UN City, Marmorvej, Copenhagen, Denmark.
  • Laxminarayan R; Center for Disease Dynamics, Economics and Policy, Washington, DC, USA; Princeton University, Princeton, NJ, USA.
  • Liébana E; Scientific Unit on Biological Hazards, European Food Safety Authority (EFSA), Parma, Italy.
  • López-Cerero L; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain.
  • MacGowan A; Department of Medical Microbiology, Southmead Hospital, Bristol, UK; EUCAST Steering Committee, Växjö, Sweden.
  • Martins M; School of Public Health, Physiotherapy and Population Science, UCD Centre for Food and Safety, Molecular Innovation and Drug Discovery, University College Dublin, Dublin, Ireland.
  • Rodríguez-Baño J; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, and Departamento de Medicina, Universidad de Sevilla, Seville, Spain; ESCMID Executive Committee, Basel, Switzerland.
  • Rolain JM; Aix-Marseille Université, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE), Inserm, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, and APHM, CHU Timone, Pôle Infectieux, Marseille, France.
  • Segovia C; Instituto de Salud Carlos III, ISCIII, Madrid, Spain.
  • Sigauque B; Centro de Investigação em Saúde da Manhiça and Instituto Nacional de Saúde/Ministério de Saúde, Maputo, Mozambique.
  • Tacconelli E; Division of Infectious Diseases, Department of Internal Medicine I, Tübingen University Hospital, Tübingen, Germany; ESCMID Executive Committee, Basel, Switzerland.
  • Wellington E; School of Life Sciences, University of Warwick, Coventry, UK.
  • Vila J; ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain; ESCMID Executive Committee, Basel, Switzerland.
New Microbes New Infect ; 8: 175, 2015 Nov.
Article in En | MEDLINE | ID: mdl-27257501